We are live on ! Find out more
PODD icon

Insulet

463 hedge funds and large institutions have $19.1B invested in Insulet in 2021 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 157 increasing their positions, 165 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more call options, than puts

Call options by funds: $74.7M | Put options by funds: $35.9M

22% more first-time investments, than exits

New positions opened: 67 | Existing positions closed: 55

5% more capital invested

Capital invested by funds: $18.1B → $19.1B (+$927M)

2% more funds holding

Funds holding: 453463 (+10)

5% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 165

3.83% less ownership

Funds ownership: 105.13%101.31% (-3.8%)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

Holders
463
Holders Change
+10
Holders Change %
+2.21%
% of All Funds
8.03%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
67
Increased
157
Reduced
165
Closed
55
Calls
$74.7M
Puts
$35.9M
Net Calls
+$38.8M
Net Calls Change
+$105M

PODD Hedge Fund Activity: Q2 2021 in Review

463 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q2 2021, worth a combined $19.1B — up 5.1% from $18.1B a quarter earlier.

Buyers outnumbered sellers: 67 funds opened new PODD positions and 55 closed out — a net gain of 12 holders — while 157 added to existing stakes and 165 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $332M. The largest seller was Winslow Capital Management, exiting entirely with an estimated $187M sold.

  • 463 institutional investors held Insulet (PODD) as of Q2 2021, up from 453 in Q1 2021.
  • Funds reported $19.1B of Insulet stock for Q2 2021, up 5.1% quarter-over-quarter.
  • 67 funds opened new Insulet positions in Q2 2021 and 55 closed out, a net change of +12 holders.
  • The largest Insulet buyer in Q2 2021 was Capital Research Global Investors, an estimated $332M added.
  • The largest Insulet seller in Q2 2021 was Winslow Capital Management, an estimated $187M sold.

Based on aggregated 13F filings for Q2 2021.